« Previous
Next »
Titles
- Radiology contrast concerns: reports of extravasation and allergic reactions1
- Ready or not?: protecting the public's health from diseases, disasters and bioterrorism : 20171
- Recommendations to improve access to mental health services for children with special health care needs in California1
- Recommended statement for over-the-counter aspirin-containing drug products labeled with cardiovascular related imagery1
- Recurrent herpes labialis: developing drugs for treatment and prevention1
- Registration and product listing for owners and operators of domestic tobacco product establishments: (revised)1
- Regulatory considerations for human cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use : guidance for industry and Food and Drug Administration staff1
- Relation between narrow networks and providers of cancer care1
- Requests for feedback on medical device submissions: the pre-submission program and meetings with Food and Drug Administration staff : guidance for industry and Food and Drug Administration staff1
- Requirements for transactions with first responders under section 582 of the Federal Food, Drug, and Cosmetic Act--compliance policy1
- Restructuring Medicaid in the American Health Care Act: five key considerations1
- Retained bioburden on surgical instruments after reprocessing: are we just scraping the surface?1
- Retained surgical items: events and guidelines revisited1
- Retirement prospects for the millennials: what is the early prognosis?1
- Rising inequality in life expectancy by socioeconomic status1
- Risk estimation and the prevention of cardiovascular disease: a national clinical guideline1
- Round 2 competitive bidding for CPAP/RAD: disrupted access unlikely for devices, inconclusive for supplies1